<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04268316</url>
  </required_header>
  <id_info>
    <org_study_id>53483</org_study_id>
    <nct_id>NCT04268316</nct_id>
  </id_info>
  <brief_title>Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder</brief_title>
  <official_title>Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to test the safety and feasibility of virtual reality&#xD;
      (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive&#xD;
      disorder (MDD). The secondary purpose of this study is to examine whether any evidence of&#xD;
      clinical efficacy exists for VR delivered BA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a treatment development trial. Participants will be randomly assigned to BA in VR, BA&#xD;
      in real-life, or a waitlist control group. The former two groups will follow a BA protocol&#xD;
      developed for primary care settings over a four-week treatment period. This study is taking&#xD;
      place over Zoom, due to COVID-19.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 18, 2020</start_date>
  <completion_date type="Actual">January 15, 2021</completion_date>
  <primary_completion_date type="Actual">January 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to either BA in VR, BA in real-life, or a waitlist control group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participant's Desire to Continue Using VR After the Study Ends</measure>
    <time_frame>Assessed at the end of week 3, after session 4</time_frame>
    <description>This outcome was measured using the &quot;Intention to use Technology &quot; questions of the Technology Acceptance Model questionnaire. These are questions 11, 12, and 13 and allow participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4). With 3 questions, the total range was 0-12 (higher scores indicate greater acceptance).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Dropped Out of Each Study Arm</measure>
    <time_frame>3-weeks</time_frame>
    <description>Participant treatment dropout was compared across each study arm. This was reported as the count of participants who discontinued the study for any reason.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant's Satisfaction With the VR-BA Treatment</measure>
    <time_frame>Assessed at the end of week 3, after session 4</time_frame>
    <description>This outcome was measured using the &quot;Attitudes Toward Use &quot; questions of the Technology Acceptance Model questionnaire. These are questions 7, 8, 9, and 10 and allow participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4). With 4 questions, the total range was 0-16 (higher scores indicate greater acceptance).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant's Use of the VR Headset</measure>
    <time_frame>Assessed at the end of week 3, after session 4</time_frame>
    <description>This was measured by noting the amount of times the VR headset is used during the 3-week study period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant's Acceptance of VR-BA Treatment</measure>
    <time_frame>Assessed at the end of week 3, after session 4</time_frame>
    <description>This was measured using the overall Technology Acceptance Model questionnaire, which encompasses 13 questions and allows participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4), yielding a range of 0-52 (higher scores indicate greater acceptance).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>How Well Can Participants Tolerate the VR-BA Treatment?</measure>
    <time_frame>Assessed at the end of week 3, after session 4</time_frame>
    <description>This was determined by the Simulator Sickness Questionnaire, which names 16 adverse symptoms and asks participants to circle as compared to baseline: No more than usual (0), Slightly more than usual (1), Moderately more than usual (2), or Severely more than usual (3), yielding a range of 0-48 (lower scores indicate greater tolerability).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>How Present Did Individuals in the VR-BA Treatment Feel?</measure>
    <time_frame>Assessed at the end of week 3, after session 4</time_frame>
    <description>This was measured using the Presence Questionnaire, which asks three questions and asks the participants to circle either Not at all (0), Slightly (1), Moderately (2), Strongly (3), or Very Strongly (4), yielding a range of 0-12 (higher scores indicate greater presence).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Depression Scores on the PHQ-9 From Baseline to Session 4, Compared Across Three Study Arms</measure>
    <time_frame>Assessed at baseline and session 4.</time_frame>
    <description>How participants' depression scores on the Patient Health Questionnaire (PHQ-9) change over time using VR-BA compared to BA in real life and a waitlist control. The PHQ-9 is a 9-question screener with a score range of 0-29, with 29 indicating the most severe depression and 0 indicating a lack of depression symptoms. The greater the change over time, the greater the symptom reduction.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Major Depressive Disorder</condition>
  <condition>MDD</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Virtual Reality Behavioral Activation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomized to this arm will perform all of their behavioral activation in virtual reality. Participants will meet with the clinician once a week for three weeks (4 sessions). In between weekly therapy sessions, participants will pick four pleasurable activities to enjoy in virtual reality.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral Activation in real-life</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to this arm will perform all of their behavioral activation in real life. Participants will meet with the clinician once a week for three weeks (4 sessions). In between weekly therapy sessions, participants will pick four pleasurable or mastery activities to perform in real life.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants randomized to this arm will not receive any type of intervention and will be asked to complete the PHQ-9 once a week for three weeks (4 sessions) to track symptoms. Participants will be offered to engage in behavioral activation in real life or with virtual reality when the four weeks are complete. Their data will only be used from the time they were on the waitlist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual Reality Behavioral Activation</intervention_name>
    <description>Participants will choose four &quot;activities&quot; to complete in virtual reality over the course of the week. These activities are video 360 and range from viewing animals, to viewing nature scenes, to traveling to a different location in the world, to viewing adrenaline-pumping activities.</description>
    <arm_group_label>Virtual Reality Behavioral Activation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Activation in real-life</intervention_name>
    <description>Participants will choose four pleasurable and/or mastery activities to complete over the course of the week in real life.</description>
    <arm_group_label>Behavioral Activation in real-life</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must meet DSM V criteria for MDD&#xD;
&#xD;
          -  Patient must be at least 18 years of age&#xD;
&#xD;
          -  Patient must be English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Substance Use Disorders in past year&#xD;
&#xD;
          -  Any psychosis or bipolar I disorder&#xD;
&#xD;
          -  Any seizure in the last 6 months or untreated epilepsy&#xD;
&#xD;
          -  Current nonsuicidal self-injury or parasuicidal behavior&#xD;
&#xD;
          -  Current suicidal urges and intent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim Bullock, MD</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Margot Paul, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Paul M, Bullock K, Bailenson J. Virtual Reality Behavioral Activation as an Intervention for Major Depressive Disorder: Case Report. JMIR Ment Health. 2020 Nov 3;7(11):e24331. doi: 10.2196/24331.</citation>
    <PMID>33031046</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <results_first_submitted>April 13, 2021</results_first_submitted>
  <results_first_submitted_qc>April 13, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 10, 2021</results_first_posted>
  <last_update_submitted>May 8, 2021</last_update_submitted>
  <last_update_submitted_qc>May 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Margot Paul</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>virtual reality</keyword>
  <keyword>behavioral activation</keyword>
  <keyword>depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No current plan to share data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 25, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT04268316/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 13, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT04268316/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>20 participants signed consent, but only 13 participants were randomized to a study arm.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Virtual Reality Behavioral Activation</title>
          <description>Participants engage in VR activities over the week for three weeks.</description>
        </group>
        <group group_id="P2">
          <title>Behavioral Activation in Real-life</title>
          <description>Participants engage in real life pleasurable activities over the week for three weeks.</description>
        </group>
        <group group_id="P3">
          <title>Waitlist Control</title>
          <description>Participants answer the PHQ-9 weekly for four sessions.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Virtual Reality Behavioral Activation</title>
          <description>Participants engage in VR activities over the week for three weeks.</description>
        </group>
        <group group_id="B2">
          <title>Behavioral Activation in Real-life</title>
          <description>Participants engage in real life pleasurable activities over the week for three weeks.</description>
        </group>
        <group group_id="B3">
          <title>Waitlist Control</title>
          <description>Participants answer the PHQ-9 weekly for four sessions.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="4"/>
            <count group_id="B4" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.6" spread="9.2"/>
                    <measurement group_id="B2" value="46" spread="15.7"/>
                    <measurement group_id="B3" value="29.5" spread="5.2"/>
                    <measurement group_id="B4" value="35.4" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>male</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-binary/third gender</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Non-Hispanic Caucasian</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chinese</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indian</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mexican</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic/Latino</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="4"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Patient Health Questionnaire-9 (PHQ-9)</title>
          <description>Total Score Depression Severity&#xD;
0 Lack of depression symptoms&#xD;
1-4 Minimal depression&#xD;
5-9 Mild depression&#xD;
10-14 Moderate depression&#xD;
15-19 Moderately severe depression&#xD;
20-27 Severe depression</description>
          <population>Participants that completed the protocol are included in the analysis.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="4"/>
                    <count group_id="B4" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.3" spread="5.7"/>
                    <measurement group_id="B2" value="15.3" spread="4.9"/>
                    <measurement group_id="B3" value="14" spread="4.1"/>
                    <measurement group_id="B4" value="14.5" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Participant's Desire to Continue Using VR After the Study Ends</title>
        <description>This outcome was measured using the &quot;Intention to use Technology &quot; questions of the Technology Acceptance Model questionnaire. These are questions 11, 12, and 13 and allow participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4). With 3 questions, the total range was 0-12 (higher scores indicate greater acceptance).</description>
        <time_frame>Assessed at the end of week 3, after session 4</time_frame>
        <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant's Desire to Continue Using VR After the Study Ends</title>
          <description>This outcome was measured using the &quot;Intention to use Technology &quot; questions of the Technology Acceptance Model questionnaire. These are questions 11, 12, and 13 and allow participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4). With 3 questions, the total range was 0-12 (higher scores indicate greater acceptance).</description>
          <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.54" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Dropped Out of Each Study Arm</title>
        <description>Participant treatment dropout was compared across each study arm. This was reported as the count of participants who discontinued the study for any reason.</description>
        <time_frame>3-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Activation in Real-life</title>
            <description>Participants engage in real life pleasurable activities over the week for three weeks.</description>
          </group>
          <group group_id="O3">
            <title>Waitlist Control</title>
            <description>Participants answer the PHQ-9 weekly for four sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Dropped Out of Each Study Arm</title>
          <description>Participant treatment dropout was compared across each study arm. This was reported as the count of participants who discontinued the study for any reason.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Participant's Satisfaction With the VR-BA Treatment</title>
        <description>This outcome was measured using the &quot;Attitudes Toward Use &quot; questions of the Technology Acceptance Model questionnaire. These are questions 7, 8, 9, and 10 and allow participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4). With 4 questions, the total range was 0-16 (higher scores indicate greater acceptance).</description>
        <time_frame>Assessed at the end of week 3, after session 4</time_frame>
        <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant's Satisfaction With the VR-BA Treatment</title>
          <description>This outcome was measured using the &quot;Attitudes Toward Use &quot; questions of the Technology Acceptance Model questionnaire. These are questions 7, 8, 9, and 10 and allow participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4). With 4 questions, the total range was 0-16 (higher scores indicate greater acceptance).</description>
          <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Participant's Use of the VR Headset</title>
        <description>This was measured by noting the amount of times the VR headset is used during the 3-week study period.</description>
        <time_frame>Assessed at the end of week 3, after session 4</time_frame>
        <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group of protocol completers only.</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant's Use of the VR Headset</title>
          <description>This was measured by noting the amount of times the VR headset is used during the 3-week study period.</description>
          <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group of protocol completers only.</population>
          <units>times used</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Participant's Acceptance of VR-BA Treatment</title>
        <description>This was measured using the overall Technology Acceptance Model questionnaire, which encompasses 13 questions and allows participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4), yielding a range of 0-52 (higher scores indicate greater acceptance).</description>
        <time_frame>Assessed at the end of week 3, after session 4</time_frame>
        <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant's Acceptance of VR-BA Treatment</title>
          <description>This was measured using the overall Technology Acceptance Model questionnaire, which encompasses 13 questions and allows participants the option of circling Strongly Disagree (0), Disagree (1), Neutral (2), Agree (3), or Strongly Agree (4), yielding a range of 0-52 (higher scores indicate greater acceptance).</description>
          <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.4" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>How Well Can Participants Tolerate the VR-BA Treatment?</title>
        <description>This was determined by the Simulator Sickness Questionnaire, which names 16 adverse symptoms and asks participants to circle as compared to baseline: No more than usual (0), Slightly more than usual (1), Moderately more than usual (2), or Severely more than usual (3), yielding a range of 0-48 (lower scores indicate greater tolerability).</description>
        <time_frame>Assessed at the end of week 3, after session 4</time_frame>
        <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>How Well Can Participants Tolerate the VR-BA Treatment?</title>
          <description>This was determined by the Simulator Sickness Questionnaire, which names 16 adverse symptoms and asks participants to circle as compared to baseline: No more than usual (0), Slightly more than usual (1), Moderately more than usual (2), or Severely more than usual (3), yielding a range of 0-48 (lower scores indicate greater tolerability).</description>
          <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" lower_limit="0.4" upper_limit="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>How Present Did Individuals in the VR-BA Treatment Feel?</title>
        <description>This was measured using the Presence Questionnaire, which asks three questions and asks the participants to circle either Not at all (0), Slightly (1), Moderately (2), Strongly (3), or Very Strongly (4), yielding a range of 0-12 (higher scores indicate greater presence).</description>
        <time_frame>Assessed at the end of week 3, after session 4</time_frame>
        <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>How Present Did Individuals in the VR-BA Treatment Feel?</title>
          <description>This was measured using the Presence Questionnaire, which asks three questions and asks the participants to circle either Not at all (0), Slightly (1), Moderately (2), Strongly (3), or Very Strongly (4), yielding a range of 0-12 (higher scores indicate greater presence).</description>
          <population>This outcome measure was assessed in the Virtual Reality Behavioral Activation group only.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Depression Scores on the PHQ-9 From Baseline to Session 4, Compared Across Three Study Arms</title>
        <description>How participants' depression scores on the Patient Health Questionnaire (PHQ-9) change over time using VR-BA compared to BA in real life and a waitlist control. The PHQ-9 is a 9-question screener with a score range of 0-29, with 29 indicating the most severe depression and 0 indicating a lack of depression symptoms. The greater the change over time, the greater the symptom reduction.</description>
        <time_frame>Assessed at baseline and session 4.</time_frame>
        <population>Protocol Completers</population>
        <group_list>
          <group group_id="O1">
            <title>Virtual Reality Behavioral Activation</title>
            <description>Participants engage in VR activities over the week for three weeks.</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Activation in Real-life</title>
            <description>Participants engage in real life pleasurable activities over the week for three weeks.</description>
          </group>
          <group group_id="O3">
            <title>Waitlist Control</title>
            <description>Participants answer the PHQ-9 weekly for four sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Depression Scores on the PHQ-9 From Baseline to Session 4, Compared Across Three Study Arms</title>
          <description>How participants' depression scores on the Patient Health Questionnaire (PHQ-9) change over time using VR-BA compared to BA in real life and a waitlist control. The PHQ-9 is a 9-question screener with a score range of 0-29, with 29 indicating the most severe depression and 0 indicating a lack of depression symptoms. The greater the change over time, the greater the symptom reduction.</description>
          <population>Protocol Completers</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" lower_limit="2" upper_limit="12"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="O3" value=".25" lower_limit="-5" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3-weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Virtual Reality Behavioral Activation</title>
          <description>Participants engage in VR activities over the week for three weeks.</description>
        </group>
        <group group_id="E2">
          <title>Behavioral Activation in Real-life</title>
          <description>Participants engage in real life pleasurable activities over the week for three weeks.</description>
        </group>
        <group group_id="E3">
          <title>Waitlist Control</title>
          <description>Participants answer the PHQ-9 weekly for four sessions.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study did not enroll to its planned sample size of 30.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Margot Paul</name_or_title>
      <organization>Stanford University</organization>
      <phone>415-625-3127</phone>
      <email>mdpaul@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

